We are live on ! Find out more
GCP

GSA Capital Partners Portfolio holdings

AUM $1.59B
1-Year Est. Return 39.81%
This Fund
S&P 500
This Quarter Est. Return
+8.03%
1 Year Est. Return
+39.81%
3 Year Est. Return
+94.75%
5 Year Est. Return
+73.44%
10 Year Est. Return
+404.29%
AUM
$1.26B
AUM Growth
+$69.7M
Cap. Flow
+$21.1M
Cap. Flow %
1.68%
Top 10 Hldgs %
3.22%
Holding
2,074
New
640
Increased
457
Reduced
456
Closed
520

Top Buys

Rank Stock Value
1
ZTS icon
Zoetis
ZTS
+$3.54M
2
MNST icon
Monster Beverage
MNST
+$3.4M
3
UGI icon
UGI
UGI
+$3.25M
4
LMND icon
Lemonade
LMND
+$3.18M
5
APA icon
APA Corp
APA
+$3.05M

Top Sells

Rank Stock Value
1
CRH icon
CRH
CRH
+$4.73M
2
AON icon
Aon
AON
+$4.58M
3
ZG icon
Zillow
ZG
+$4.44M
4
URNM icon
Sprott Uranium Miners ETF
URNM
+$4.08M
5
BWXT icon
BWX Technologies
BWXT
+$3.63M

Sector Composition

Rank Sector Weight
1 Technology 15.86%
2 Financials 12.61%
3 Healthcare 12.06%
4 Consumer Discretionary 11.89%
5 Industrials 9.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLDP icon
1501
Solid Power
SLDP
$532M
$87K 0.01%
42,756
-85,375
-67% -$130K
OMGA
1502
DELISTED
Omega Therapeutics, Inc. Common Stock
OMGA
$86K 0.01%
+23,649
New +$90.7K
HCAT icon
1503
Health Catalyst
HCAT
$128M
$84K 0.01%
11,169
-28,685
-72% -$262K
ALDX icon
1504
Aldeyra Therapeutics
ALDX
$93.5M
$83K 0.01%
25,249
-143,514
-85% -$472K
CVGI icon
1505
Commercial Vehicle Group
CVGI
$147M
$83K 0.01%
+12,912
New +$83.4K
OSUR icon
1506
OraSure Technologies
OSUR
$279M
$83K 0.01%
+13,519
New +$98.2K
ME
1507
DELISTED
23andMe Holding Co
ME
$80K 0.01%
7,547
-2,163
-22% -$27.8K
AVIR icon
1508
Atea Pharmaceuticals
AVIR
$420M
$77K 0.01%
19,071
-130,807
-87% -$512K
AMPX icon
1509
Amprius Technologies
AMPX
$1.73B
$76K 0.01%
+28,579
New +$106K
LYEL icon
1510
Lyell Immunopharma
LYEL
$360M
$76K 0.01%
+1,709
New +$73.2K
KRON
1511
DELISTED
Kronos Bio
KRON
$75K 0.01%
57,347
+32,201
+128% +$36.7K
OMER icon
1512
Omeros
OMER
$959M
$75K 0.01%
+21,755
New +$82.7K
ORGN
1513
DELISTED
Origin Materials
ORGN
$75K 0.01%
4,917
-4,249
-46% -$73.7K
AKYA
1514
DELISTED
Akoya BioSciences
AKYA
$74K 0.01%
+15,765
New +$81.9K
FUBO icon
1515
FuboTV Inc
FUBO
$273M
$74K 0.01%
3,892
-5,436
-58% -$142K
RSI icon
1516
Rush Street Interactive
RSI
$2.88B
$70K 0.01%
+10,775
New +$58K
CATO icon
1517
Cato Corp
CATO
$66.1M
$69K 0.01%
12,037
-89,862
-88% -$600K
ATER icon
1518
Aterian
ATER
$5.37M
$67K 0.01%
+24,385
New +$104K
PMVP icon
1519
PMV Pharmaceuticals
PMVP
$63.5M
$67K 0.01%
+39,637
New +$74K
MNTK icon
1520
Montauk Renewables
MNTK
$255M
$66K 0.01%
+15,895
New +$99.7K
DDL
1521
Dingdong
DDL
$503M
$64K 0.01%
+52,098
New +$67.2K
BCLI
1522
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$63K 0.01%
+7,416
New +$40.8K
NIO icon
1523
NIO
NIO
$11.9B
$63K 0.01%
+14,058
New +$84.8K
CURV icon
1524
Torrid Holdings
CURV
$260M
$62K ﹤0.01%
+12,780
New +$63.1K
BCAB icon
1525
BioAtla
BCAB
$5.74M
$61K ﹤0.01%
+354
New +$44K

Similar funds

GSA Capital Partners's Q1 2024 Portfolio in Review

As of Q1 2024, GSA Capital Partners held 2,074 positions worth $1.26B, up 5.9% from $1.19B the previous quarter. Its ten largest holdings account for 3.2% of the portfolio.

GSA Capital Partners's Q1 2024 filing shows 640 new, 457 increased, 456 reduced and 520 closed positions. Its largest new stake was Zoetis: 18,907 shares worth $3.2M. The largest sale was CRH, an estimated $4.73M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

  • GSA Capital Partners's largest Q1 2024 buy was Zoetis: 18,907 shares worth $3.2M.
  • GSA Capital Partners added most to Monster Beverage in Q1 2024, an estimated $3.4M increase.
  • GSA Capital Partners's biggest Q1 2024 reduction was CRH, cutting an estimated $4.73M.
  • GSA Capital Partners fully exited Aon in Q1 2024, selling an estimated $4.58M.
  • GSA Capital Partners's ten largest holdings make up 3.2% of its $1.26B portfolio in Q1 2024.
  • GSA Capital Partners opened 640 new positions and closed 520 in Q1 2024.
  • GSA Capital Partners's portfolio value rose 5.9% quarter-over-quarter to $1.26B.

Based on GSA Capital Partners's 13F filing for Q1 2024, filed 3 May 2024.